US approves first cancer drug to use patient's own cells (theguardian.com)

> some fear it could spur wave of highly expensive drugs

While I absolutely believe pharma companies price-gouge to the best of their abilities (charge what desperate people are willing to pay, not what is required to recoup the investment), I don't see how this drug makes it any worse. Besides, it's new, and may yet come down in price.